CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
Myung-Ju Ahn, Ji-Youn Han, Dong-Wan Kim, Byoung Chul Cho, Jin-Hyoung Kang, Sang-We Kim, James Chih-Hsin Yang, Tetsuya Mitsudomi, Jong Seok Lee
Cancer Research and Treatment. 2020;52(1):284-291.   Published online 2019 July 23    DOI: https://doi.org/10.4143/crt.2019.200

Excel Download

468P Osimertinib in patients with T790M mutation positive advanced non-small cell lung cancer (NSCLC): Korean subgroup analysis from pooled phase II data
Annals of Oncology. 2016;27:ix150   Crossref logo
Link1 Link2

Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
Cancer Research and Treatment. 2020;52(1):284-291   Crossref logo
Link1 Link2 Link3

Overall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: Results from two phase II studies
Annals of Oncology. 2017;28:v482   Crossref logo
Link1 Link2 Link3

Osimertinib for Japanese patients with T790M‐positive advanced non‐small‐cell lung cancer: A pooled subgroup analysis
Cancer Science. 2019;110(9):2884-2893   Crossref logo
Link1 Link2 Link3 Link4

Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer
Targeted Oncology. 2017;12(4):555-562   Crossref logo
Link1 Link2 Link3

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer
Lung Cancer. 2018;126:133-138   Crossref logo
Link1 Link2

Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer
Lung Cancer. 2019;129:110-111   Crossref logo
Link1 Link2

Differential efficacy of Osimertinib in EGFR T790M positive non-small cell lung cancer by metastatic site
Annals of Oncology. 2019;30:vi109   Crossref logo
Link1 Link2 Link3 Link4

3113 AZD9291 in pre-treated patients with T790M positive advanced non-small cell lung cancer (NSCLC): Pooled analysis from two Phase II studies
European Journal of Cancer. 2015;51:S640   Crossref logo
Link1 Link2

Osimertinib in patients with T790M mutation‐positive, advanced non–small cell lung cancer: Long‐term follow‐up from a pooled analysis of 2 phase 2 studies
Cancer. 2018;125(6):892-901   Crossref logo
Link1 Link2 Link3 Link4

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.